Clinical trial
A Randomized, Double-Blind Clinical Study of Peiyuan Guben Tongluo Ointment in the Treatment of Elderly Sarcopenia (Spleen-Kidney Deficiency Syndrome) With Two Internal and External Controls
NCT07538674 is registered in ClinicalTrials.gov with Shanghai Yueyang Integrated Medicine Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind Clinical Study of Peiyuan Guben Tongluo Ointment in the Treatment of Elderly Sarcopenia (Spleen-Kidney Deficiency Syndrome) With Two Internal and External Controls
- Lead sponsor
- Shanghai Yueyang Integrated Medicine Hospital
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sarcopenia in elderly